Searchable abstracts of presentations at key conferences in endocrinology

ea0029p1130 | Neuroendocrinology | ICEECE2012

Fasting induces a delayed increase of thyrotropin-releasing hormone degrading ectoenzyme activity in the tanycytes of the median eminence of the rat hypothalamus

Lazcano I. , Joseph-Bravo P. , Sanchez E. , Charli J.

Fasting produces a rapid reduction of the activity of the central arm of the hypothalamic–pituitary–thyroid (HPT) axis, with a drop in biosynthesis of thyrotropin releasing hormone (TRH) in periventricular and medial parvocellular neurons of the paraventricular nucleus (PVN), and decreased TRH release into the pituitary portal capillaries. These events contribute to fasting-induced suppression of serum thyroid hormone levels, an adaptive mechanism to conserve energy....

ea0029p1815 | Thyroid cancer | ICEECE2012

Calcitonin levels in washout of cytology needle on thyroid nodule without suspicion of medullary thyroid carcinoma

Martin T. , Garcia C. , Gonzalez N. , Sanchez P. , Barco A. , Martin V. , Sendon A.

Introduction: We study the calcitonin levels measurement in the washout of FNAB needles after sampling each thyroid nodule (FNAB-CT) as an approach to calcitonin normal value in them and distinguish of MTC and to correlate with serum CT (sCT) and cytology FNAB.Material & Methods: 109 consecutive subjects (mean age 53.7±13.4, range 18–85 yr, 79.8% females, 27.5% smokers, 18.3% autoimmune thyroid disease) initially no suspicious for MTC who u...

ea0029p112 | Adrenal cortex | ICEECE2012

Adrenal masses as the first demonstration of non endocrine tumors metastatic disease

Palmeiro R. , Paramo C. , Sanchez P. , Seoane I. , Trigo C. , Lopez Y. , Luna R. , Penin M. , Garcia-Mayor R.

Introduction: Adrenal lesions occur in more than 10% of the general population. Most are benign, but 2.5% are metastatic disease to the adrenal from tumors such melanoma, renal, breast, colon and lung carcinoma. Adrenal metastatic disease is usually asymptomatic and diagnosed in the extension study or the primary tumor. However it is unusual as a presentation of an endocrine tumor or like the first manifestation of metastatic disease.We present two patie...

ea0029p593 | Diabetes | ICEECE2012

Three novel mutations in maturity-onset diabetes of the young genes in Spain

Palmeiro R. , Luna R. , Seoane I. , Trigo C. , Sanchez P. , Lopez Y. , Penin M. , Paramo C. , Garcia-Mayor R.

Introduction: Maturity-onset diabetes of the young (MODY) is a genetically, metabolically and clinically heterogeneous subtype of diabetes mellitus characterized by an early onset, an autosomal dominant inheritance, and a primary defect in insulin secretion. They are caused by mutations in a reduced number of β-cell genes. Mutations in glucokinase gen (MODY 2) and hepatic nuclear factor 1α (HNF 1α) (MODY 3) are the most common.Materials an...

ea0029p1216 | Obesity | ICEECE2012

Age variations in adiposity and body fat composition among spanish women

Pedrera-Zamorano J. , Roncero-Martin R. , Calderon-Garcia J. , Rodriguez-Dominguez T. , Rey-Sanchez P. , Canal-Macias M.

Objective: To characterize the age variations of fatness pattern in Spanish womenResearch methods and procedures:: A cross-sectional study of 2226 Spanish women (16 to 74 years old) women was undertaken to study age variations in adiposity, body composition, obesity and central fat distribution. The women were divided into seven groups: Group I (G I, 15–24 years), Group II (G II, 25–34 years), Group III (G III, 35–44 years), Group IV (G IV...

ea0063gp233 | Anterior and Posterior Pituitary | ECE2019

Evaluation of postoperative copeptin concentration as a predictive factor of diabetes insipidus after pituitary surgery. preliminary results

Navarro-Hoyas C , Gotarredona J Serrano , Delegido-Gomez L , Alfayate R , Serrano Corredor S , Revert Marrahi P , Sanchez-Ortiga R , Alfonso A Pico

Introduction: Central diabetes insipidus (DI) is observed in up to 34% of patients undergoing pituitary surgery. Early postoperative diagnosis of DI is critical because its detection allows early treatment, reducing morbidity and hospital stay. AVP levels measurement is not commonly used to diagnose DI. As an alternative, copeptin determination has been proposed, but its usefulness has only been validated in one series.Objective: To define the threshold ...

ea0056ep63 | Diabetes, Obesity and Metabolism | ECE2018

Sympathetic hyperactivity and sleep disorders: is Type 2 diabetes the link between these two situations?

Lopez-Cano Carolina , Gutierrez-Carrasquilla Liliana P , Sanchez Enric , Gaeta Anna M , Marti Raquel , Hernandez Marta , Cao Gonzalo , Ribelles Merce , Gomez Xavier , Sanchez Marta , Mizab Chadia , Barbe Ferran , Lecube Albert

Results: Main clinical, analytical and polygraphic data: 58.1±6.4 years, body mass index 32.4±5.4 kg/m2, 70.4% female, HbA1c 8.0±1.9%, AIH 27.4 events/hour (in the range of severe sleep apnea and hypoapnea index), and CT90% 32.9%. Nocturnal concentration of urine total metanephrines were higher than diurnal levels (226±12 vs 98±13 μg/l; P=0.085). In addition, its nocturnal concentration was significantly associated, in a positi...